栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/12/04 | 2,475 | 2,488 | 2,431 | 2,435 | -15 | -0.6% | 128,600 |
| 2025/12/03 | 2,481 | 2,492 | 2,450 | 2,450 | -40 | -1.6% | 75,800 |
| 2025/12/02 | 2,453 | 2,510 | 2,453 | 2,490 | +23 | +0.9% | 81,900 |
| 2025/12/01 | 2,470 | 2,498 | 2,454 | 2,467 | -11 | -0.4% | 70,500 |
| 2025/11/28 | 2,433 | 2,489 | 2,430 | 2,478 | +21 | +0.9% | 103,900 |
| 2025/11/27 | 2,482 | 2,492 | 2,440 | 2,457 | -25 | -1% | 90,800 |
| 2025/11/26 | 2,415 | 2,488 | 2,408 | 2,482 | +67 | +2.8% | 129,900 |
| 2025/11/25 | 2,373 | 2,439 | 2,355 | 2,415 | +72 | +3.1% | 102,300 |
| 2025/11/21 | 2,282 | 2,344 | 2,282 | 2,343 | +65 | +2.9% | 78,800 |
| 2025/11/20 | 2,261 | 2,302 | 2,260 | 2,278 | +27 | +1.2% | 87,500 |
| 2025/11/19 | 2,306 | 2,306 | 2,228 | 2,251 | -71 | -3.1% | 131,500 |
| 2025/11/18 | 2,350 | 2,363 | 2,317 | 2,322 | -51 | -2.1% | 105,900 |
| 2025/11/17 | 2,350 | 2,378 | 2,349 | 2,373 | +23 | +1% | 77,700 |
| 2025/11/14 | 2,350 | 2,356 | 2,333 | 2,350 | +10 | +0.4% | 105,600 |
| 2025/11/13 | 2,350 | 2,364 | 2,330 | 2,340 | -10 | -0.4% | 70,700 |
| 2025/11/12 | 2,350 | 2,366 | 2,342 | 2,350 | +26 | +1.1% | 59,400 |
| 2025/11/11 | 2,329 | 2,338 | 2,316 | 2,324 | +4 | +0.2% | 69,600 |
| 2025/11/10 | 2,330 | 2,337 | 2,309 | 2,320 | +8 | +0.3% | 82,200 |
| 2025/11/07 | 2,301 | 2,325 | 2,293 | 2,312 | -18 | -0.8% | 65,100 |
| 2025/11/06 | 2,350 | 2,363 | 2,320 | 2,330 | -20 | -0.9% | 98,600 |
| 2025/11/05 | 2,372 | 2,396 | 2,320 | 2,350 | -35 | -1.5% | 124,800 |
| 2025/11/04 | 2,349 | 2,437 | 2,345 | 2,385 | +31 | +1.3% | 87,600 |
| 2025/10/31 | 2,363 | 2,366 | 2,325 | 2,354 | +4 | +0.2% | 88,900 |
| 2025/10/30 | 2,347 | 2,363 | 2,330 | 2,350 | +21 | +0.9% | 125,000 |
| 2025/10/29 | 2,366 | 2,377 | 2,306 | 2,329 | -52 | -2.2% | 112,400 |
| 2025/10/28 | 2,406 | 2,433 | 2,378 | 2,381 | -46 | -1.9% | 74,100 |
| 2025/10/27 | 2,380 | 2,431 | 2,380 | 2,427 | +46 | +1.9% | 45,700 |
| 2025/10/24 | 2,374 | 2,395 | 2,350 | 2,381 | -2 | -0.1% | 56,300 |
| 2025/10/23 | 2,372 | 2,409 | 2,372 | 2,383 | -6 | -0.3% | 50,500 |
| 2025/10/22 | 2,357 | 2,405 | 2,357 | 2,389 | +36 | +1.5% | 72,900 |
| 2025/10/21 | 2,324 | 2,371 | 2,324 | 2,353 | +29 | +1.2% | 33,800 |
| 2025/10/20 | 2,362 | 2,362 | 2,312 | 2,324 | +12 | +0.5% | 32,000 |
| 2025/10/17 | 2,320 | 2,336 | 2,300 | 2,312 | -2 | -0.1% | 56,600 |
| 2025/10/16 | 2,336 | 2,336 | 2,304 | 2,314 | ±0 | ±0% | 35,200 |
| 2025/10/15 | 2,309 | 2,331 | 2,309 | 2,314 | +32 | +1.4% | 38,900 |
| 2025/10/14 | 2,301 | 2,330 | 2,256 | 2,282 | -59 | -2.5% | 67,800 |
| 2025/10/10 | 2,327 | 2,363 | 2,323 | 2,341 | -25 | -1.1% | 46,300 |
| 2025/10/09 | 2,343 | 2,394 | 2,305 | 2,366 | -19 | -0.8% | 50,900 |
| 2025/10/08 | 2,381 | 2,423 | 2,381 | 2,385 | -21 | -0.9% | 38,300 |
| 2025/10/07 | 2,368 | 2,413 | 2,368 | 2,406 | +11 | +0.5% | 51,000 |
| 2025/10/06 | 2,419 | 2,420 | 2,389 | 2,395 | +24 | +1% | 47,700 |
| 2025/10/03 | 2,313 | 2,389 | 2,312 | 2,371 | +40 | +1.7% | 58,200 |
| 2025/10/02 | 2,340 | 2,349 | 2,300 | 2,331 | +1 | ±0% | 67,500 |
| 2025/10/01 | 2,371 | 2,385 | 2,316 | 2,330 | -64 | -2.7% | 113,600 |
| 2025/09/30 | 2,430 | 2,443 | 2,385 | 2,394 | -41 | -1.7% | 111,200 |
| 2025/09/29 | 2,440 | 2,456 | 2,431 | 2,435 | -43 | -1.7% | 72,700 |
| 2025/09/26 | 2,435 | 2,487 | 2,429 | 2,478 | +23 | +0.9% | 129,300 |
| 2025/09/25 | 2,474 | 2,475 | 2,446 | 2,455 | +2 | +0.1% | 73,300 |
| 2025/09/24 | 2,445 | 2,465 | 2,430 | 2,453 | +3 | +0.1% | 49,200 |
| 2025/09/22 | 2,430 | 2,471 | 2,430 | 2,450 | -3 | -0.1% | 51,500 |
151~
200
件表示中 / 7241件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 254,500円 | +0.2% | +2.0% | 2.28% | 40.53倍 | 1.91倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
| 持田薬 | 311,500円 | +7.7% | +11.7% | 2.73% | 11.01倍 | 0.78倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 205,400円 | +6.6% | +17.7% | 2.43% | 9.05倍 | 0.84倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 90,900円 | +39.5% | - | 0.00% | 15.31倍 | 1.38倍 |
|
創薬ベンチャー老舗。買収で成長。低分子で定評の英国創薬事業、日本の製造販売が事業2本柱 |
| サンバイオ | 103,500円 | - | - | 0.00% | - | 6.06倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム